Loading…
Loading…
Hinge Health Inc. (NYSE: HNGE - Get Free Report) CEO Daniel Perez sold 4,100 shares of Hinge Health stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $100.20, for a total value of $410,820.00. Following the completion of the sale, the chief executive officer directly owned 4,100 shares
Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial mar
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relation.
Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as $99.73 and last traded at $98.6050, with a volume of 973880 shares traded. The stock had previously closed at $97.67. Wall Street Analyst Weigh In A number of equities research analysts have
Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday. The company traded as high as $97.95 and last traded at $94.3050, with a volume of 157292 shares traded. The stock had previously closed at $92.45. Analyst Ratings Changes Several brokerages recently issued reports on HNGE. Barclays
The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.
Hinge Health Inc. (NYSE: HNGE - Get Free Report) President James Pursley sold 33,000 shares of Hinge Health stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $94.14, for a total transaction of $3,106,620.00. Following the completion of the sale, the president owned 666,909 shares of